Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

Expertise in Nasal Delivery

3D Nasal Cast Model


SNBL’s Comments on Results from Clinical Phase 3 Studies of STS101, an Investigational Migraine Drug Candidate, Announced by Satsuma Pharmaceuticals, Inc.

Please see the original SNBL Press Release from here.